Emotions Immunology and Breast Cancer
NCT03609671 is an interventional trial sponsored by Luz A. Venta, MD. As of 21 Nov 2026, it is completed. It studies Breast Cancer, Emotions and 2 more conditions. The registry lists an enrollment of 17 participants at 2 sites in 1 country. The registry lists a start date of 23 Nov 2015 and a primary completion date of 18 Mar 2019.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT03609671 |
| Status | Completed |
| Study type | Interventional trial |
| Lead sponsor | Luz A. Venta, MD |
| Enrollment | 17 |
| Registered sites | 2 |
| Countries | 1 |
| Conditions | Breast Cancer, Emotions, Immunology and Triple Negative Breast Cancer |
| Start | 23 Nov 2015 |
| Primary completion | 18 Mar 2019 |
| Study completion | 18 Mar 2019 |
| Last update posted | 28 Aug 2019 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Luz A. Venta, MD
The Methodist Hospital Research Institute
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Houston Methodist Hospital
Houston
- Houston Methodist Hospital Cancer Center
Houston
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Questions about NCT03609671
Each answer restates registry values shown on this page.
What is NCT03609671?
NCT03609671 is an interventional trial sponsored by Luz A. Venta, MD. It studies Breast Cancer, Emotions and 2 more conditions.
Who leads NCT03609671?
The registry names Luz A. Venta, MD (principal investigator, The Methodist Hospital Research Institute) as the overall official.
Where does NCT03609671 run?
The registry lists 2 sites in 1 country. Every site with a stated country is in one country: United States.
When did NCT03609671 end?
The registry lists a primary completion date of 18 Mar 2019 and a study completion date of 18 Mar 2019. The sponsor last updated the record on 28 Aug 2019.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.